Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.

MLA

Hassanzadeh, Comron, et al. “Early Outcomes Following Local Salvage Treatment with MRI-Assisted Low-Dose Rate Brachytherapy (MARS) for MRI-Visible Postsurgical Bed Recurrences and Focal Intraprostatic Recurrences.” Brachytherapy, Jan. 2025. EBSCOhost, https://doi.org/10.1016/j.brachy.2024.10.015.

APA

Hassanzadeh, C., Mohamad, O., Bruno, T., Wang, L., Kudchakar, R., Bathala, T., Sanders, J., Mok, H., McGuire, S., Kuban, D., Hoffman, K., Nguyen, Q., Park, R., Thames, H., Corn, P., Chapin, B., Choi, S., Tang, C., & Frank, S. (2025). Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy. https://doi.org/10.1016/j.brachy.2024.10.015

Chicago

Hassanzadeh, Comron, Osama Mohamad, Teresa Bruno, Lin Wang, Rajat Kudchakar, Tharakeswara Bathala, Jeremiah Sanders, et al. 2025. “Early Outcomes Following Local Salvage Treatment with MRI-Assisted Low-Dose Rate Brachytherapy (MARS) for MRI-Visible Postsurgical Bed Recurrences and Focal Intraprostatic Recurrences.” Brachytherapy, January. doi:10.1016/j.brachy.2024.10.015.